THOMAS GODFREY: Open Payments
NPI 1235543281 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 9 payments from 7 companies in 2025. Trend: 2023 $725 · 2024 $191 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $245 |
| Boston Scientific Corporation | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| CVRx, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
Products named: QULIPTA, ELUVIA, LEQVIO, Barostim Neo System, VERQUVO, Kerendia, REPATHA.
Industry payments across SC — which companies pay providers there.
